Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

MicroRNA-126Àº HIF-1¥áÀÇ ¹ßÇöÀ» ÅëÇØ ±¸°­ ÆíÆò»óÇǼ¼Æ÷¾ÏÀÇ Áõ½Ä´É°ú ÀÌÁÖ´ÉÀ» ÃËÁøÇÑ´Ù

MicroRNA-126 Promotes the Proliferation and Migration of Oral Squamous Cell Carcinoma Cells Via HIF-1¥á Expression

´ëÇѱ¸°­¾Ç¾È¸éº´¸®ÇÐȸÁö 2023³â 47±Ç 1È£ p.13 ~ 23
¹Ú¼ö¿¬, ¿ÀÁöÇö, ÀÌ»ó½Å, ÃÖÁ¾È£,
¼Ò¼Ó »ó¼¼Á¤º¸
¹Ú¼ö¿¬ ( Park Su-Yeon ) - Gangneung-Wonju National University College of Dentistry Department of Pathology
¿ÀÁöÇö ( Oh Ji-Hyeon ) - Gangneung-Wonju National University College of Dentistry Department of Oral and Maxillofacial Surgery
ÀÌ»ó½Å ( Lee Sang-Shin ) - Gangneung-Wonju National University College of Dentistry Department of Pathology
ÃÖÁ¾È£ ( Choi Jong-Ho ) - Gangneung-Wonju National University College of Dentistry Department of Pathology

Abstract


Oral squamous cell carcinoma (OSCC) is the most common type of head and neck cancer and is associated with high recurrence, poor treatment, and low survival rates. Hypoxia-inducible factor-1¥á (HIF-1¥á) is a transcription factor that regulates the response to hypoxia, a major factor in the tumor microenvironment that affects tumor development and progression in various cancer types. However, microRNA (miRNA) sequence analysis revealed that only a few miRNAs targeting HIF-1¥á had been discovered. In the present study, we investigated HIF-1¥á expression in OSCC and the effect of HIF-1¥á-targeting miRNAs on the progression and metastatic potential of OSCC. We analyzed public databases to explore which miRNAs target HIF-1¥á expression. In addition, the expression of proteins involved in the cell cycle, proliferation, and apoptosis in HSC-2 cells was analyzed after miRNA-126 mimic treatment. Furthermore, to investigate the effect of miRNA-126 on the proliferation and invasion ability of OSCC cells, 5-ethynyl-2¡Ç-deoxyuridine and Transwell assays were performed. The activities of MMP-2 and MMP-9 were evaluated via gelatin zymography. Our results showed that miRNA-126, which targets HIF-1¥á, enhances OSCC cell proliferation by regulating the cell cycle and reinforces the cell mobility of OSCC via HIF-1¥á expression. These findings suggest that miRNA-126 may be a novel marker for OSCC treatment and the development of new tools for patients with OSCC.

Å°¿öµå

Oral squamous cell carcinoma; MicroRNAs; HIF-1¥á; Metastasis; Proliferation

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI